WebThe key valuation ratios of Divis Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone. 3. Is Divis Laboratories Ltd a good buy now? The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Divis Laboratories Ltd is likely to Rise-somewhat in the short term ... WebNov 8, 2024 · Divi's Laboratories Q2 earnings. Jefferies has downgraded its rating on shares of Divi's Laboratories to 'hold' following the Q2 revenue and EBITDA miss as compared to its estimates. Pfizer's COVID oral drug candidate Paxlovid shows the efficacy of 89 percent, which could pose a threat to Divi's Laboratories' Molnupiravir prospects.
Brokerages downgrade Divi
WebCheck Divi''s Lab share price, financial data and complete stock analysis.Get Divi''s Lab stock rating based on quarterly result, profit and loss account, balance sheet, … Web3.07B. -66.00%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue. 17.97. -50.35%. Earnings per share. Represents the company's profit divided by ... gold necklace chains for pendants
Why Divi
WebDivi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered … WebAnswer (1 of 2): Divis Labs limited is one of the finest drug manufacturer with impeccable management record of giving good returns to the investors. The chart below indicates the consistent performance on the bourses Buy on declines and hold long term WebDivis Laboratories Ltd. ₹ 2,788 -0.81%. 10 Mar - close price. Export to Excel. divislaboratories.com BSE: 532488 NSE : DIVISLAB. About. Divis Laboratories Ltd is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. gold necklace chain women\u0027s